Excellence
in Corporate Development
Excellence
in Corporate Development
|
Meet us at the JP Morgan Healthcare Conference, San Francisco, January 7 - 10, 2019 |
|
Meet us at the JP Morgan Conference, San Francisco |
|
Binder Associates GmbH advised Glycotope on the sale of Gycotope Biotechnology Manufacturing Site |
|
Binder Associates GmbH advised Natrix Separations Inc. on the exit preparation and sale to Merck |
|
Binder Associates advised world–wide acting family office on the sale of a biopharmaceutical portfolio company |
|
Meet us at the JP Morgan Conference, 2017 San Francisco |
|
Binder Associates GmbH advised Biomeva Holding GmbH on the sale of Biomeva GmbH to Asahi Glass (AGC) |
|
Binder Associates successfuly initiates funded collaboration between a client and a large Pharma company |
|
10th Binder Associates Business Development Forum |
|
Binder Associates GmbH supported Cellca GmbH in the sale to Sartorius AG |
|
Binder Associates GmbH advised Bionet Holding on the sale of scil animal care company to Henry Schein Inc. |
|
Start of an exit preparation project with a Germany based technology provider |
|
Binder Associates and Freshfields advised Bionet on the acquisition of Scil Proteins by Wacker Biotech |
|
Succesful outlicensing of a biologics project |
For more information please contact info@binder-associates.de
Binder Associates
Rankinestraße 4 · 86899 Landsberg am Lech
Phone: +49 8191 9856 335 · Mail: info@binder-associates.de